Pricing 'tweak' could halve industry profits, claim experts
This article was originally published in Scrip
Executive Summary
Last minute tweaks in India's new drug pricing policy, which were cleared by the Cabinet on 22 November, could wipe out large chunks of industry's profits, with some experts anticipating potential changes in the production strategy of domestic firms as well as shortages of medicines in some segments in the medium to long term.